FMP
electroCore, Inc.
ECOR
NASDAQ
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
15.27 USD
0.75 (4.91%)
About
ceo
Mr. Daniel S. Goldberger
sector
Healthcare
industry
Medical - Devices
website
https://www.electrocore.comexchange
NASDAQ
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
CIK
0001560258
ISIN
US28531P2020
CUSIP
28531P103
Address
200 Forge Way
Phone
973 290 0097
Country
US
Employee
68
IPO Date
Jun 22, 2018
Key Executives
